<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Platelet function and morphologic characteristics were evaluated in 43 patients with <z:mpath ids='MPATH_512'>myeloproliferative disease</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>), 5 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and 7 patients with secondary <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo> (ST) </plain></SENT>
<SENT sid="1" pm="."><plain>Platelet Factor IV (<z:chebi fb="0" ids="30203">PF4</z:chebi>) and B-thromboglobulin (BTG) showed slight elevation in ST but significant elevation in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>They were either <z:mpath ids='MPATH_458'>normal</z:mpath> or slightly elevated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0003540'>Defective platelet aggregation</z:hpo> with one or more inducers was seen in 62% of <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="4" pm="."><plain>An <z:chebi fb="2" ids="28918">epinephrine</z:chebi>-induced defect was the most consistent aggregation abnormality </plain></SENT>
<SENT sid="5" pm="."><plain>Hyperaggregation and spontaneous aggregation were seen in 15% of patients </plain></SENT>
<SENT sid="6" pm="."><plain>Of the eight patients who showed increased <z:hpo ids='HP_0001892'>bleeding tendency</z:hpo>, <z:hpo ids='HP_0000001'>all</z:hpo> eight showed defective aggregation with two or more inducers, five showed decreased surface activation response, as well as decreased or abnormal granules and dense tubular disarray in the transmission electron microscope (TEM) study </plain></SENT>
<SENT sid="7" pm="."><plain>Seven patients had clinical evidence of recurrent arterial and venous thromboses </plain></SENT>
<SENT sid="8" pm="."><plain>Five of these patients showed hyperaggregation response to <z:chebi fb="3" ids="16335">adenosine</z:chebi> <z:chebi fb="2" ids="18361">diphosphate</z:chebi> and collagen and abnormal Wu and Hoak platelet aggregate ratio </plain></SENT>
<SENT sid="9" pm="."><plain>Four patients showed spontaneous aggregation on aggregometer </plain></SENT>
<SENT sid="10" pm="."><plain>Surface activation response was significantly increased in five patients, and an increase in platelet granules by TEM study was seen in four patients </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">Primary thrombocythemia</z:e> could be differentiated from secondary <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo> (ST) by the presence of abnormal aggregation response and significantly increased <z:chebi fb="0" ids="30203">PF4</z:chebi> and BTG in the former, and greatly elevated plasma fibrinogen and Factor VIII, as part of <z:hpo ids='HP_0011009'>acute</z:hpo> phase reactant response, in the latter </plain></SENT>
</text></document>